---
created: 2025-04-13
updated: 2025-04-13T10:52
id: k{|b[R|ZcQ
specialty: pharmaco
specialty_id: 252
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::02-platelet-activation
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::07-anticoagulants
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::03-physiology::03-platelet-plug-formation-(primary-hemostasis)::sketchy-pharm
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::04-pharm::01-arachidonic-acid-pathway
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::04-pharm::01-arachidonic-acid-pathway::antiplatelet-agents-sketch
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::13-hematology-oncology::11-hemostasis
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::01-anticoagulants-&-thrombolytics::03-antiplatelet-agents
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::6000-6999::6515
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield"
type: flashcard
---

# Question
TXA2 causes vaso-**constriction**

---

# Answer
